sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Acne Vulgaris: Epidemiology Forecasting Intelligence

Acne Vulgaris: Epidemiology Forecasting Intelligence

Home / Categories / Healthcare
Acne Vulgaris: Epidemiology Forecasting Intelligence
Acne Vulgaris: Epidemiology Forecasting Intelligence
Report Code
RO1/114/1054

Publish Date
01/Mar/2019

Pages
50-70
PRICE
$ 2500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1. Report Introduction
2. Acne Vulgaris Epidemiology Overview at a Glance
3. Market Share Distribution of Acne Vulgaris
4. Disease Background and Overview: Acne Vulgaris
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Acne Vulgaris Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Acne Vulgaris by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Acne Vulgaris
7.3. Sub-Type Specific cases of Acne Vulgaris*
7.4. Sex- Specific Cases of Acne Vulgaris*
7.5. Diagnosed Cases of Acne Vulgaris
7.6. Treated Cases of Acne Vulgaris
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Acne Vulgaris
8.1.3. Sub-Type Specific cases of Acne Vulgaris*
8.1.4. Sex- Specific Cases of Acne Vulgaris*
8.1.5. Diagnosed Cases of Acne Vulgaris
8.1.6. Treated Cases of Acne Vulgaris
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Acne Vulgaris
8.2.3. Sub-Type Specific cases of Acne Vulgaris*
8.2.4. Sex- Specific Cases of Acne Vulgaris*
8.2.5. Diagnosed Cases of Acne Vulgaris
8.2.6. Treated Cases of Acne Vulgaris
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Acne Vulgaris
8.3.3. Sub-Type Specific cases of Acne Vulgaris*
8.3.4. Sex- Specific Cases of Acne Vulgaris*
8.3.5. Diagnosed Cases of Acne Vulgaris
8.3.6. Treated Cases of Acne Vulgaris
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Acne Vulgaris
8.4.3. Sub-Type Specific cases of Acne Vulgaris*
8.4.4. Sex- Specific Cases of Acne Vulgaris*
8.4.5. Diagnosed Cases of Acne Vulgaris
8.4.6. Treated Cases of Acne Vulgaris
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Acne Vulgaris
8.5.3. Sub-Type Specific cases of Acne Vulgaris*
8.5.4. Sex- Specific Cases of Acne Vulgaris*
8.5.5. Diagnosed Cases of Acne Vulgaris
8.5.6. Treated Cases of Acne Vulgaris
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Acne Vulgaris
9.3. Sub-Type Specific cases of Acne Vulgaris*
9.4. Sex- Specific Cases of Acne Vulgaris*
9.5. Diagnosed Cases of Acne Vulgaris
9.6. Treated Cases of Acne Vulgaris
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com